FAQ

Losing 50–100 strands of hair daily is within the normal range. Hair grows in cycles — shedding is part of the natural telogen (resting) phase. If you notice clumping, visible thinning patches, or a receding hairline, consult a trichologist for evaluation.

Male Pattern Hair Loss (MPHL), or Androgenetic Alopecia (AGA), is the most common cause of hair loss in men. It is caused by a genetic sensitivity of hair follicles to dihydrotestosterone (DHT), a derivative of testosterone. It typically progresses from a receding hairline and thinning crown (Norwood Classification Grades I–VII). Treatment is more effective when started early.

Female hair loss has multiple causes including: Female Pattern Hair Loss (FPHL), thyroid disorders (hypo or hyperthyroidism), PCOS (Polycystic Ovarian Syndrome), Alopecia Areata (autoimmune), nutritional deficiencies (iron, ferritin, vitamin D, zinc), Telogen Effluvium (post-pregnancy, post-illness, or stress-induced shedding), certain medications, and crash dieting. A thorough blood workup and trichoscopy are required for accurate diagnosis.

Yes. Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can disrupt the hair growth cycle, pushing follicles prematurely into the resting phase and causing diffuse shedding across the scalp. Jata Hair Sciences evaluates thyroid function as part of its diagnostic protocol for unexplained hair loss.

Yes. Significant physical or emotional stress can trigger Telogen Effluvium — a condition where a large number of follicles enter the shedding phase simultaneously. This typically presents as diffuse hair loss 2–3 months after a stressful event (surgery, illness, bereavement, extreme dieting). It is often reversible once the underlying stressor resolves.

A hair transplant is a surgical procedure that permanently relocates hair follicles from a DHT-resistant donor area (usually the back and sides of the scalp) to areas of thinning or baldness. It is recommended for patients with stable hair loss, adequate donor density, and realistic expectations about coverage and density. Jata Hair Sciences conducts a detailed assessment before recommending surgery.

FUE (Follicular Unit Extraction): Individual follicles extracted with a micro-punch. Minimal scarring (tiny dots). Preferred for patients who prefer short hairstyles.

FUT (Follicular Unit Transplantation): A strip of scalp is excised and dissected into grafts. Linear scar at donor site. Allows harvesting more grafts in one session.

DHI (Direct Hair Implantation): Uses a Choi pen for simultaneous extraction and implantation. Offers precise angle, direction, and depth control. Often preferred for hairline design.

Sapphire Blade FUE uses blades tipped with synthetic sapphire crystals (instead of steel) to create recipient channels. The harder material allows smaller, more precise incisions that reduce scalp trauma, minimise post-operative crusting, and enable higher graft density. Dr. Vinay Chouksey at Jata Hair Sciences is trained in the Sapphire Blade technique.

The number of grafts depends on the extent of hair loss (Norwood grade), desired coverage, and donor density. Rough estimates: Grade III receding hairline: 1,500–2,500 grafts. Grade V–VI advanced loss: 3,000–5,000 grafts. A proper assessment by Dr. Vinay Chouksey is needed for an accurate graft count.

Standard FUE sessions are 4–8 hours. Larger "mega sessions" covering advanced baldness may be 10–12 hours. DHI procedures for hairline work may take 4–6 hours. Sessions are performed under local anaesthesia on an outpatient basis.

Days 1–3: Mild swelling of forehead and scalp. Prescribed medications manage discomfort.

Days 4–7: Crusting at recipient and donor sites; gentle washing begins.

Week 2: Most patients return to work. Avoid sun, swimming, and exercise.

Weeks 2–8: Transplanted hair sheds (shock loss). This is normal and expected.

Month 3–4: New hair growth begins.

Month 6–9: Visible coverage improvement.

Month 12–18: Final results visible.

The procedure is performed under local anaesthesia. Patients may feel pressure but not sharp pain during the procedure. Post-operative discomfort is mild and managed with prescribed analgesics for 2–3 days.

FUE is considered a low-risk procedure when performed by a qualified surgeon. Potential side effects: temporary swelling, itching, or numbness; shock loss of native hair (usually temporary); infection (rare); folliculitis (temporary). Serious complications are rare and are discussed during pre-procedure counselling with Dr. Vinay Chouksey.

PRP (Platelet-Rich Plasma) involves extracting the patient's blood, centrifuging it to concentrate platelets, and injecting the growth-factor-rich plasma into the scalp. Clinical studies show PRP improves hair density and thickness in Androgenetic Alopecia and Alopecia Areata when administered in a series of sessions (typically 3–6 monthly injections, then maintenance). Results vary by patient and hair loss stage.

Regenera Activa is a CE-marked, non-surgical treatment using autologous micrografts (processed from a 2–4mm punch biopsy of the patient's scalp) rich in progenitor cells and growth factors. These are injected into the thinning area to stimulate regrowth. The procedure takes approximately 45 minutes with no downtime. Visible improvement is typically noted within 2–3 months.

QR 678 is a proprietary Indian-developed growth factor cocktail for non-surgical hair restoration. It combines multiple growth factors (FGF, VEGF, PDGF, EGF) in a single solution injected into the scalp. Approved and clinically validated in India. Used for Androgenetic Alopecia, Alopecia Areata, and diffuse thinning in both genders.

SMP is a specialised cosmetic tattooing technique that uses micro-needles to deposit pigment into the scalp dermis, mimicking the appearance of hair follicles or adding the illusion of density. Used for: complete scalp coverage in advanced alopecia, hairline definition, FUT scar camouflage, and adding density to thin areas. Results last 3–5 years before colour refresh may be needed.